[Treatment of visceral leishmaniasis].


Aim of this report is to review the most important therapeutical choices in visceral leishmaniasis. The pentavalent antimonial derivatives (PAD) remain the first-line drugs despite the toxicity and the wide resistance. Among the other therapeutical options, the importance of lipid formulations of amphotericin B is emphasized; it is a valid resource for the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.